![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, September 03, 2010 11:26:09 PM
It received the official no-objection letter from the Food and Drug Administration (FDA) on January 6 this year, accepting Fuji's GRAS notification which was filed with the FDA on July 7, 2009.
Prior to FDA notification a panel of experts convening in June 2009 independently determined that AstaREAL astaxanthin was GRAS.
AstaREAL astaxanthin is a member of the carotenoid family of natural pigments closely related to beta carotene, lycopene and lutein. It is a natural biological antioxidant found most abundantly in seafood that gives the pink and red color to salmon, shrimp and lobster.
However, animals as well as humans depend on their diet to obtain astaxanthin and other carotenoids since neither can produce it themselves.
AstaREAL astaxanthin has been marketed globally (including the US) for years as a dietary ingredient for use in supplements.
Now as the first and only astaxanthin to attain GRAS status, AstaREAL is also permitted to be marketed as an ingredient in food and beverages within the US.
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM